Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
3(25%)
Results Posted
25%(1 trials)
Terminated
2(17%)

Phase Distribution

Ph not_applicable
2
17%
Ph phase_2
2
17%
Ph phase_4
6
50%
Ph early_phase_1
1
8%
Ph phase_1
1
8%

Phase Distribution

2

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
6(50.0%)
N/ANon-phased studies
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)
Other(3)

Detailed Status

Completed4
unknown3
Active, not recruiting2
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (8.3%)
Phase 11 (8.3%)
Phase 22 (16.7%)
Phase 46 (50.0%)
N/A2 (16.7%)

Trials by Status

completed433%
active_not_recruiting217%
recruiting18%
terminated217%
unknown325%

Recent Activity

3 active trials
Showing 5 of 12
recruitingphase_2

Metronidazole as Preoperative Therapy in CRC / FusoMetro-001

NCT05748145
active_not_recruitingphase_2

Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone

NCT04827537
completedearly_phase_1

Vaginal lIve Biotherapeutic RANdomized Trial

NCT06135974
active_not_recruitingphase_4

The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery

NCT04554693
terminatedphase_4

Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis

NCT05788991
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT05748145Phase 2

Metronidazole as Preoperative Therapy in CRC / FusoMetro-001

Recruiting
NCT04827537Phase 2

Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone

Active Not Recruiting
NCT06135974Early Phase 1

Vaginal lIve Biotherapeutic RANdomized Trial

Completed
NCT04554693Phase 4

The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery

Active Not Recruiting
NCT05788991Phase 4

Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis

Terminated
NCT03954990Phase 1

Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity

Terminated
NCT04682522Phase 4

Flagyl Microbiome in Crohn's Disease

Completed
NCT03593252Not Applicable

Bowel Preparation in Elective Pediatric Colorectal Surgery

Unknown
NCT03939273Not Applicable

The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery

Unknown
NCT04391998Phase 4

Parasitic Infection in Anemic Pregnant Women

Unknown
NCT03099408Phase 4

Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis

Completed
NCT03343509Phase 4

Topical Versus Oral Metronidazole Following Excisional Haemorrhoidectomy

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12